(S)-1-(4-Bromothiophen-2-yl)ethanamine hydrochloride, 98%, 5g

5-Bromo-3-iodo-4,7-diazaindole, 95.0%, 10g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-7-(tert-butoxy)-7-oxoheptanoic acid, 95+%, 100mg

(7-methyl-2-oxo-2H-chromen-4-yl)acetic acid, 95.0%, 1g

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 4 - MWCO 12,000 to 14,000, 45 mm, 30 m, 1 Piece(s)

cyclobutyl 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone, 97.0%, 1g

Pentadecanoic acid, 95.0%, 10g

Chromium carbide, 99.5% metals basis, 500g

HPTLC Plates RP-18 W / UV254 - octadecyl-modified, 20 x 20 cm, 0.25 mm, 25 Piece(s)

(4-Methylpyridin-3-yl)methylamine, 95.0%, 10g

tri-Sodium citrate dihydrate, 1 kg

4-(4-(1,2,2-Triphenylvinyl)phenyl)pyridine, 98%, 1g

2-CHLORO-6-METHYL-3-NITROPYRIDIN-4-AMINE, 95.0%, 250mg